文献速递消化道肿瘤与早癌肝病

识别胃肠肿瘤诊断评估延迟的触发算法的开发与验证

Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-08-10

研究利用美国退伍军人事务部电子健康记录数据,开发并验证了两种触发算法,用于识别结直肠癌(CRC)和肝细胞癌(HCC)疑似发现后诊断评估延迟的患者。算法对CRC延迟随访的阳性预测值为56.0%(95%CI 51.0%-61.0%),对HCC为82.3%(95%CI 74.4%-88.2%);外推至全部异常结果患者,CRC敏感性68.6%、特异性81.1%,HCC敏感性89.1%、特异性96.5%。与非选择性方法相比,算法将需审查以识别一次延迟的记录数减少99%以上。

要点

  • 触发算法可高效识别CRC和HCC诊断评估延迟,大幅减少病历审查工作量。
  • CRC算法阳性预测值56.0%,HCC算法阳性预测值82.3%。
  • 外推后CRC敏感性68.6%、特异性81.1%;HCC敏感性89.1%、特异性96.5%。

核心结论

  • 利用退伍军人事务部电子健康记录数据库数据开发的算法大幅减少了识别疑似CRC或HCC患者随访评估延迟所需的病历审查数量,为识别胃肠肿瘤诊断评估延迟提供了更高效的方法。

研究设计与样本

  • 研究基于美国退伍军人事务部国家企业数据仓库的实验室、诊断、操作和转诊代码,开发并验证了两种触发算法,分别检测CRC和HCC诊断评估延迟。
  • CRC算法应用于2013年1月1日至2013年12月31日就诊的245,158例患者,识别出1,073例延迟随访患者,并随机抽取400份记录进行审查。
  • HCC算法应用于2011年1月1日至2014年12月31日就诊的333,828例患者,识别出130例延迟随访患者,并对全部130份记录进行人工审查。

主要发现

  • CRC算法在随机抽取的400份记录审查中,识别延迟随访的阳性预测值为56.0%(95%CI 51.0%-61.0%)。
  • HCC算法在全部130份记录审查中,识别延迟随访的阳性预测值为82.3%(95%CI 74.4%-88.2%)。
  • 外推至全部异常结果患者,CRC算法识别延迟随访评估的敏感性为68.6%(95%CI 65.4%-71.6%),特异性为81.1%(95%CI 79.5%-82.6%)。
  • 外推至全部异常结果患者,HCC算法识别延迟随访评估的敏感性为89.1%(95%CI 81.8%-93.8%),特异性为96.5%(95%CI 94.8%-97.7%)。
  • 与非选择性方法相比,使用算法将识别一次延迟所需审查的记录数减少99%以上。

关键数值与推荐

  • CRC触发算法初始识别铁缺乏性贫血或粪便免疫化学试验阳性患者,排除终末期疾病或已在60天内完成随访评估者。
  • HCC触发算法初始识别甲胎蛋白升高患者,排除终末期疾病或已在60天内完成随访评估者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Colorectal cancer (CRC) and hepatocellular cancer (HCC) are common causes of death and morbidity, and patients benefit from early detection. However, delays in follow-up of suspicious findings are common, and methods to efficiently detect such delays are needed. We developed, refined, and tested trigger algorithms that identify patients with delayed follow-up evaluation of findings suspicious of CRC or HCC. METHODS: We developed and validated two trigger algorithms that detect delays in diagnostic evaluation of CRC and HCC using laboratory, diagnosis, procedure, and referral codes from the Department of Veteran Affairs National Corporate Data Warehouse. The algorithm initially identified patients with positive test results for iron deficiency anemia or fecal immunochemical test (for CRC) and elevated α-fetoprotein results (for HCC). Our algorithm then excluded patients for whom follow-up evaluation was unnecessary, such as patients with a terminal illness or those who had already completed a follow-up evaluation within 60 days. Clinicians reviewed samples of both delayed and nondelayed records, and review data were used to calculate trigger performance. RESULTS: We applied the algorithm for CRC to 245,158 patients seen from January 1, 2013, through December 31, 2013 and identified 1073 patients with delayed follow up. In a review of 400 randomly selected records, we found that our algorithm identified patients with delayed follow-up with a positive predictive value of 56.0% (95% CI, 51.0%-61.0%). We applied the algorithm for HCC to 333,828 patients seen from January 1, 2011 through December 31, 2014, and identified 130 patients with delayed follow-up. During manual review of all 130 records, we found that our algorithm identified patients with delayed follow-up with a positive predictive value of 82.3% (95% CI, 74.4%-88.2%). When we extrapolated the findings to all patients with abnormal results, the algorithm identified patients with delayed follow-up evaluation for CRC with 68.6% sensitivity (95% CI, 65.4%-71.6%) and 81.1% specificity (95% CI, 79.5%-82.6%); it identified patients with delayed follow-up evaluation for HCC with 89.1% sensitivity (95% CI, 81.8%-93.8%) and 96.5% specificity (95% CI, 94.8%-97.7%). Compared to nonselective methods, use of the algorithm reduced the number of records required for review to identify a delay by more than 99%. CONCLUSIONS: Using data from the Veterans Affairs electronic health record database, we developed an algorithm that greatly reduces the number of record reviews necessary to identify delays in follow-up evaluations for patients with suspected CRC or HCC. This approach offers a more efficient method to identify delayed diagnostic evaluation of gastroenterological cancers.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Murphy DR, Meyer AND, Vaghani V, et al. Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer. Clin Gastroenterol Hepatol. 2017. PMID: 28804030. doi:10.1016/j.cgh.2017.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。